pharmaphorum

JULY 5, 2022

The medicines – which include insulin, oral diabetes agent glibenclamide and cancer chemotherapy oxaliplatin – will be sold under a new Impact brand and are all classed as essential medicines by the World Health Organisation (WHO). ” The post Sanofi makes low-cost medicines pledge for low-income countries appeared first on.

Diabetes 119

Diabetes Chemotherapy Vaccines 119

Pharmaceutical Technology

AUGUST 1, 2022

Since 2020, government agencies have provided funding for expensive late-stage vaccine development and the expansion of manufacturing capacity, as well as other key pharmaceutical activities. The shift from private to public funding enabled more rapid development of Covid-19 drugs and vaccines.

Vaccines 93

Vaccines Pharmaceutical Companies Pharmaceutical Companies Chemotherapy 93

Digital Pharmacist

FEBRUARY 27, 2023

As the prevalence of cancer is continuing to increase, the role of the pharmacist becomes more important to help prevent any drug-drug interactions between these medications and chemotherapy and counseling patients on the proper use and appropriateness of certain OTC products. Vaccinations can be given before, during, and after chemotherapy.

Chemotherapy 52

Chemotherapy Vaccines Scheduling Appointments Communication 52

European Pharmaceutical Review

JULY 26, 2022

The CHMP also recommended an extension of the use of the smallpox vaccine Imvanex (live modified vaccinia virus Ankara) to include protecting adults from monkeypox and disease caused by vaccinia virus. Rubraca referral outcome. The CHMP also recommended approving a new manufacturing site for the finished product in Madrid, Spain.

Vaccines 105

Vaccines Diabetes Chemotherapy 105

Pharmaceutical Technology

SEPTEMBER 14, 2022

Early-stage cervical cancer patients achieve good recovery through surgery and concurrent chemotherapy, but treatment options are scarce for those with recurrent metastatic cervical cancer. months, combination treatment with Libtayo and chemotherapy significantly lowered the risk of death by 34% in the study cohort. In both the PD-L1?1%

Vaccines 59

Vaccines Chemotherapy Dosage 59

pharmaphorum

SEPTEMBER 16, 2021

The US regulator has cleared the tyrosine kinase inhibitor (TKI) as a second-line treatment for locally advanced or metastatic non-small-cell lung cancer (NSCLC) patients whose tumours have EGFR exon20 insertion mutations, after first-line chemotherapy.

Chemotherapy 105

Chemotherapy Vaccines 105

pharmaphorum

NOVEMBER 23, 2022

Regeneron has announced that the European Commission (EC) has approved Libtayo (cemiplimab) as a monotherapy for the treatment of adult patients with second-line recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy. The results were published in the New England Journal of Medicine.

Chemotherapy 59

Chemotherapy Labelling Immunity Immunization 59

epicur

JULY 12, 2023

Chemo Blister Packs For safer, more convenient treatment Epicur® chemotherapy tablets are manufactured in our FDA Registered Outsourcing Facility following cGMP. Personalized care throughout the treatment process We know side effects of chemotherapy treatment can be difficult for your patients and their owners. Targeted drug therapy.

Immunity 85

Immunity Immunization Chemotherapy Vaccines 85

pharmaphorum

SEPTEMBER 25, 2020

The FDA now says it will fast track review of DKN-01 as a second-line therapy for DKK-positive G/GEJ cancers after prior fluoropyrimidine- and platinum- containing chemotherapy as well as anti-HER2 drugs if those have been deemed appropriate.

Immunity 72

Immunity Immunization Chemotherapy Hospitals 72

pharmaphorum

APRIL 16, 2021

GSK decided to stop enrolling patients on the phase 2 INDUCE-3 trial, discontinuing treatment with feladilimab and has also axed the INDUCE-4 phase 2 trial, testing feladilimab versus placebo in combination with Keytruda and chemotherapy. billion signed with Germany’s Merck KGaA.

Packaging 69

Packaging Chemotherapy Vaccines 69

European Pharmaceutical Review

JUNE 27, 2023

How do you envision microbiome therapies complementing existing cancer treatments, such as chemotherapy and immunotherapy? He has also held the role of Vice President and Therapeutic Area Head, Vaccine Clinical Research at Merck & Co. What will most impact the future development of microbiome therapies?

Immunity 105

Immunity Immunization Chemotherapy Vaccines 105

pharmaphorum

MARCH 15, 2021

A phase 3 trial of the PD-1 inhibitor in cervical cancer patients who had progressed after first-line chemotherapy has been stopped early after an interim look at the data showed that the drug cut mortality by 31% compared to second-line chemo. The median overall survival with Libtayo (cemiplimab) was 12 months, compared to 8.5

Chemotherapy 52

Chemotherapy Vaccines 52

RX Note

MARCH 28, 2023

Prevention The most effective way to prevent the disease is vaccination. WHO recommends annual vaccination for Pregnant women at any stage of pregnancy Children aged between 6 months to 5 years Elderly individuals (aged more than 65 years) Individuals with chronic medical conditions Health-care workers.

Long-Term Care Facilities 40

Long-Term Care Facilities Nursing Homes Vaccines Hospitals 40

pharmaphorum

DECEMBER 23, 2020

It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. months in patients treated with chemotherapy. In the 500 patient trial, patients treated with Trodelvy lived for a median of 12.1 months, compared with 6.7

Chemotherapy 96

Chemotherapy Compounding Vaccines 96

pharmaphorum

JULY 19, 2021

Recent successes in FDA approvals of antibody–drug conjugates (ADCs), RNA therapeutics and the UK’s regulatory leadership in coronavirus vaccines show that complex medicines are having a global impact. But the benefits of complex medicines go far beyond those we have seen with these vaccines.

Vaccines 52

Vaccines Chemotherapy 52

pharmaphorum

NOVEMBER 24, 2020

Even past the second wave, as vaccines become available, healthcare systems will not return rapidly to pre-pandemic capacities, let alone deliver more than that capacity. The pharmaceutical industry has risen magnificently to the challenge of COVID-19, in terms of treatment and vaccine development.

Pharmaceutical Companies 90

Pharmaceutical Companies Pharmaceutical Companies Vaccines Diabetes 90

pharmaphorum

AUGUST 22, 2022

Chemotherapy, the current standard of care for cancer treatment, can be harmful to both the cancer cells and the body’s healthy cells. ” Moderna has also created a personalised cancer vaccine, a similar idea where the vaccine is built against the specific cancer one has in the body.

Vaccines 102

Vaccines Chemotherapy Immunity Immunization 102

European Pharmaceutical Review

DECEMBER 12, 2023

IPH5201 is being investigated in a Phase II trial, MATISSE, in combination with durvalumab (anti-PD-L1) and chemotherapy, in patients with resectable early-stage NSCLC. Innate Pharma also developing IPH5201 in collaboration with AstraZeneca.

Immunity 124

Immunity Immunization Chemotherapy Pharmaceutical Companies 124

pharmaphorum

JANUARY 27, 2021

Indeed, efforts to contain the virus in the absence of a vaccine have been based on the use of health data, giving the wider public an awareness of its importance and power within the health system. The COVID-19 pandemic has raised awareness about many facets of the NHS, including its capabilities to produce and leverage health data.

Hospitals 143

Hospitals Chemotherapy Vaccines 143

InCrowd

AUGUST 18, 2022

These treatments have yielded huge gains, with improved overall survival, fewer side-effects and improved patient quality of life; far better than the “sledgehammer” approach of chemotherapy. By improving sanitation and with the use of vaccines, we were able to reduce infections. Shah SC, Kayamba V, Peek RM, Jr., Heimburger D.

Vaccines 52

Vaccines Chemotherapy 52

RX Note

FEBRUARY 6, 2025

Medications that have to be refrigerated are mainly injections , which comprises of insulins, vaccines, immunoglobulins and biologics. Theoretically, this piece of information may smoothen the process of searching an unknown drug. In my reading, there are few important key points that I come to realise.

Vaccines 40

Vaccines Dosage Chemotherapy Labelling 40

pharmaphorum

NOVEMBER 14, 2022

The narrower label for Zejula (niraparib) means it can only be used as second-line maintenance therapy after platinum-based chemotherapy in patients with these cancers whose tumours carry a germline BRCA mutation – around 15% of the population. The post GSK hits another oncology hurdle as Zejula use is limited again appeared first on.

Labelling 52

Labelling Chemotherapy Vaccines 52

pharmaphorum

SEPTEMBER 8, 2020

In England for instance, the introduction of a biosimilar to prevent neutropenia in patients undergoing chemotherapy, resulted in a number of Strategic Health Authorities reassessing their guidance relating to this medicine.

Biosimilars 99

Biosimilars Drug Pricing Chemotherapy Vaccines 99

pharmaphorum

APRIL 7, 2021

There’s potential for combination drugs, paving the way for less toxic chemotherapy-free cancer drugs. It has brought a lot of good things working together and networking has led to unbelievable successes,” he added, noting the rapid development of vaccines by companies such as Pfizer/BioNTech, Moderna and AstraZeneca/Oxford University.

Chemotherapy 91

Chemotherapy Hospitals Vaccines 91

Pharmaceutical Technology

JUNE 30, 2022

The Nature publication touches on this in the case of platinum-based chemotherapy. There, copy number changes can be used to differentiate between patients who respond to platinum chemotherapy and those who do not, explains Markowetz. At the moment, high mutational burden can be used to determine response to immunotherapies.

Chemotherapy 52

Chemotherapy Drug Development Hospitals Vaccines 52

Pharmaceutical Technology

JANUARY 30, 2023

In a Complete Response Letter to Eli Lilly in March 2022, the FDA indicated that the Oncologic Drug Advisory Committee voted overwhelmingly in favour of requiring more research to support the approval of sintilimab with pemetrexed and platinum-based chemotherapy for nonsquamous non-small cell lung cancer.

Biosimilars 52

Biosimilars Diabetes Chemotherapy Vaccines 52

epicur

JANUARY 30, 2023

For the past two years, I was a territory manager in Philadelphia and Delaware where I was responsible for calling on general practice accounts, selling various products, anything from IV lines, flea, tick, and heartworm products to vaccines to capital equipment. So more of the overall drug side of things. And that’s what led me to Epicur.

Compounding 52

Compounding Dosage Chemotherapy Communication 52

RX Note

JUNE 3, 2023

State the immunoglobulin, vaccines and antivenoms available in your facility. What are the prechemotherapy checks before initiating chemotherapy. Which chemotherapy drugs can be given via intrathecal route? Discuss common side effects of chemotherapy and the management plan. Define TNM classification.

Health and Personal Care Stores 40

Health and Personal Care Stores Chemotherapy Compounding Dosage 40

Pharmaceutical Technology

JULY 23, 2008

With expensive new treatments, increasing numbers of patients in chemotherapy in major markets and developing nations like China, Brazil and Russia investing more in treating and diagnosing cancer, IMS predicts a compound growth rate of 12–15% and tips the global market to reach $80bn by 2012.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Compounding Biosimilars 40

European Pharmaceutical Review

JANUARY 18, 2023

Pfizer has announced it is expanding its ‘An Accord for a Healthier World’ initiative, to include its full portfolio of medicines and vaccines for which Pfizer has global rights. The initial not-for-profit offering provided access to all its patented medicines and vaccines available in the US or European Union (EU) to 1.2

Vaccines 98

Vaccines Chemotherapy Communication 98

Pharmaceutical Technology

MARCH 2, 2023

Keytruda is indicated in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) in patients whose tumors express PD-L1 and who have received at least one prior chemotherapy regimen. It is also indicated for the treatment of metastatic transitional (urothelial) tract cancer and gastric cancer.

Chemotherapy 40

Chemotherapy Vaccines Diabetes Immunity 40

pharmaphorum

JANUARY 27, 2023

Evusheld (tixagevimab and cilgavimab) was cleared by the FDA towards the end of 2021, becoming the first antibody to be authorised for prevention of COVID-19 infection, and it rapidly found use among people with compromised immune systems, such as cancer chemotherapy and organ-transplant patients.

Chemotherapy 135

Chemotherapy Immunity Immunization Vaccines 135

European Pharmaceutical Review

DECEMBER 21, 2022

Researchers predicted Artemis-SCID patients would need less chemotherapy to prepare their marrow for transfusion when their own cells were being used, so only 25 percent of a full dose of busulfan was administered. The second outcome was T-cell reconstitution at 12 months, a measurement of the strength of the immune system.

Immunity 105

Immunity Immunization Chemotherapy Vaccines 105

European Pharmaceutical Review

DECEMBER 19, 2022

The group adopted a positive opinion for Tremelimumab AstraZeneca (tremelimumab), to treat metastatic non-small cell lung cancer (NSCLC) in combination with Imfinzi (durvalumab) and platinum-based chemotherapy. The committee recommended to extend the use of original Spikevax vaccine and Spikevax bivalent Original/Omicron BA.1

Generic Medicine 104

Generic Medicine Vaccines Chemotherapy 104

European Pharmaceutical Review

APRIL 3, 2023

It is the eighth vaccine recommended in the European Union (EU) for COVID-19. The committee recommended granting a paediatric-use marketing authorisation (PUMA) for Pedmarqsi (sodium thiosulfate) for preventing ototoxicity induced by cisplatin chemotherapy. Cisplatin is a chemotherapy used to treat several types of cancer.

Vaccines 98

Vaccines Chemotherapy Generic Medicine Biosimilars 98

RX Note

FEBRUARY 23, 2023

- Discussing the 4 main drug targets Functional Groups - Quick refresh on IUPAC nomenclature Drug Potency - Refresh on drug potency Drug Metabolism - Discussing Phase I and II reactions, as well as CYP450 system Pharmacogenomics - Discussing some examples Miscellaneous Continuous Professional Development - Needed for renewal of annual retention Immunization (..)

HIV Treatment and Prevention Agents 58

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 58

LifeProNow

APRIL 19, 2023

The safety of immunization with live viral vaccines during or after ABECMA treatment has not been studied. Vaccination with live virus vaccines is not recommended for at least 6 weeks prior to the start of lymphodepleting chemotherapy, during ABECMA treatment, and until immune recovery following treatment with ABECMA.

Adverse Reactions 100

Adverse Reactions Vaccines Immunity Immunization 100